Tissue
Cascades’ containerboard business drives Q3 results
The company’s sequentially stronger sales are attributed to its containerboard segment, where higher average selling prices and lower production expenses offset higher raw material costs.
More in Tissue
Cascades Q2 earnings down from last year; CEO says Bear Island ramp-up remains priority
The company reports nearly $728,000 in Q2 net earnings compared with $1.6 million in the same period last year, but the company expects stronger Q3 results.
Wait and see?
Muted consumer spending and the upcoming presidential election have pushed the high-grade recovered paper market down. But are better times ahead?
Clearwater Paper to sell tissue business to Sofidel America Corp.
The $1.06 billion transaction will accelerate the company’s efforts to delever its balance sheet by reducing net debt.
Cascades reports net loss in Q1; CEO says results met expectations
The company expects second quarter results to be stronger sequentially, driven by improved performance in containerboard.
Italian paper company buys ST Paper tissue mill in Minnesota
Global tissue paper producer Sofidel says the purchase allows it to meet ongoing demand increases.
Clearwater Paper to use CNG recycled PE in packaging options
The initiative will include the use of advanced recycled polyethylene from Charter Next Generation in Clearwater’s private-label tissue packaging offerings.
Essity consumes cartons at French mill
European tissue producer says it now can recycle more than half of France’s cartons and aseptic packaging at its mill in Hondouville, France.
Consolidation efforts continue as low volumes persist
As some paper and packaging companies have deployed optimization strategies this year, low mill volumes have affected second-quarter earnings at companies across the U.S.
Cascades to fully close St. Helens, Oregon, tissue plant
The move comes after the company previously announced it would shut down its virgin tissue paper machine at the facility.
Tissue grades continue to tumble
Unlike with bulk grades, there appears to be little hope on the horizon for tissue grades, which have been facing their own challenging market condition.
